FTC passes final order in USD 4 billion Sun-Ranbaxy deal
US anti-trust regulator FTC has passed its final order settling charges that Sun Pharma's USD 4 billion deal to acquire Ranbaxy Laboratories could result in unfair business practices.
Mar 20, 2015, 23:11 PM IST